Benjamin Hohl, CFO: Enliven Therapeutics ELVN Planned sale · Filed 09/17

Trade details

Type: Planned sale notice
Stock: Enliven Therapeutics ELVN
Person: Benjamin HohlCFO
Planned sale date: 26/09/17
Filed: 26/09/17

More to sell after $932.9K in 3 months

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 08/18~10/17

Benjamin Hohl's recent trades

Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$149.2K
3,401 sh
$149.2K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$59K
1,379 sh
$59K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$55.4K
1,238 sh
$55.4K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$768.2K
18,054 sh
$768.2K
Filed 06/17
Traded 06/17
Benjamin HohlCFO
SellEnliven Therapeutics
Sell
Enliven Therapeutics
ELVN
$295.8K
10,000 sh
$295.8K
Filed 03/10
Traded 03/06

Benjamin Hohl, CFO — plans to sell 12,036 sh of Enliven Therapeutics ELVN · $591.2K · around 09/17 · 10b5-1 plan | Whalegun